Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways

Fig. 1

Antiproliferation effects of benzimidazoisoquinoline derivatives in human glioblastoma cells. Chemical structures of the synthetic benzimidazoisoquinoline derivatives were labeled by compounds 1AI. IC50 values were also obtained after 48 h with treatment of compounds 1AI at concentrations of 3.125–50 μmol/L in U87 and LN229 cells and represented as percentage of control as mean ± SD of experiments performed at least three times

Back to article page